Screener
Aurinia Pharmaceuticals AUPH Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndCashEquivalents.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's restricted cash?
- Aurinia Pharmaceuticals (AUPH) reported restricted cash of $100K in Q2 2026.
- How has Aurinia Pharmaceuticals's restricted cash changed year-over-year?
- Aurinia Pharmaceuticals's restricted cash increased by 13.6% year-over-year, from $88K to $100K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Aurinia Pharmaceuticals's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude